ESR1 and breast cancer: Previous studies on MAGI1 have shown that its downregulation in ER+HER2− BC cells generates a more aggressive phenotype [21] and that silencing MAGI1 in colorectal cancer cells accelerates primary tumor growth and promotes metastasis [20].